Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury

Yuki Kinoshita, Syunsuke Kondo, Kazuya Takahashi, Jun Nagai, Shuji Wakatsuki, Toshiyuki Araki, Yoshio Goshima, Toshio Ohshima

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Axonal degeneration occurs in patients with various neurological diseases and traumatic nerve injuries, and Wallerian degeneration is a phenomenon in the prototypical axonal degradation that is observed after injury. Collapsin response mediator protein 2 (CRMP2) is phosphorylated by glycogen synthase kinase 3β (GSK3β), and it is involved in Wallerian degeneration after optic nerve injury. We previously developed a CRMP2 knock-in (CRMP2 KI) mouse line, in which CRMP2 phosphorylation by GSK3β is inhibited; however, Wallerian degeneration in CRMP2 KI mice has not yet been examined. In this study, we examined whether Wallerian degeneration of the optic nerve is suppressed in CRMP2 KI mice. Using one eye removal model, we compared Wallerian degeneration of the optic nerve based on histological and biochemical analyses. Our experimental results indicated that the genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury.

Original languageEnglish
JournalBiochemical and Biophysical Research Communications
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Optic Nerve Injuries
Wallerian Degeneration
Phosphorylation
Optics
Glycogen Synthase Kinase 3
Optic Nerve
Nerve Degeneration
Wounds and Injuries
collapsin response mediator protein-2
Degradation

Keywords

  • Genetic
  • Mouse
  • Neurodegeneration
  • Optic nerve
  • Phosphorylation

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury. / Kinoshita, Yuki; Kondo, Syunsuke; Takahashi, Kazuya; Nagai, Jun; Wakatsuki, Shuji; Araki, Toshiyuki; Goshima, Yoshio; Ohshima, Toshio.

In: Biochemical and Biophysical Research Communications, 01.01.2019.

Research output: Contribution to journalArticle

Kinoshita, Yuki ; Kondo, Syunsuke ; Takahashi, Kazuya ; Nagai, Jun ; Wakatsuki, Shuji ; Araki, Toshiyuki ; Goshima, Yoshio ; Ohshima, Toshio. / Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury. In: Biochemical and Biophysical Research Communications. 2019.
@article{ff943395c08e4f0da76e739604c77131,
title = "Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury",
abstract = "Axonal degeneration occurs in patients with various neurological diseases and traumatic nerve injuries, and Wallerian degeneration is a phenomenon in the prototypical axonal degradation that is observed after injury. Collapsin response mediator protein 2 (CRMP2) is phosphorylated by glycogen synthase kinase 3β (GSK3β), and it is involved in Wallerian degeneration after optic nerve injury. We previously developed a CRMP2 knock-in (CRMP2 KI) mouse line, in which CRMP2 phosphorylation by GSK3β is inhibited; however, Wallerian degeneration in CRMP2 KI mice has not yet been examined. In this study, we examined whether Wallerian degeneration of the optic nerve is suppressed in CRMP2 KI mice. Using one eye removal model, we compared Wallerian degeneration of the optic nerve based on histological and biochemical analyses. Our experimental results indicated that the genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury.",
keywords = "Genetic, Mouse, Neurodegeneration, Optic nerve, Phosphorylation",
author = "Yuki Kinoshita and Syunsuke Kondo and Kazuya Takahashi and Jun Nagai and Shuji Wakatsuki and Toshiyuki Araki and Yoshio Goshima and Toshio Ohshima",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.bbrc.2019.05.060",
language = "English",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury

AU - Kinoshita, Yuki

AU - Kondo, Syunsuke

AU - Takahashi, Kazuya

AU - Nagai, Jun

AU - Wakatsuki, Shuji

AU - Araki, Toshiyuki

AU - Goshima, Yoshio

AU - Ohshima, Toshio

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Axonal degeneration occurs in patients with various neurological diseases and traumatic nerve injuries, and Wallerian degeneration is a phenomenon in the prototypical axonal degradation that is observed after injury. Collapsin response mediator protein 2 (CRMP2) is phosphorylated by glycogen synthase kinase 3β (GSK3β), and it is involved in Wallerian degeneration after optic nerve injury. We previously developed a CRMP2 knock-in (CRMP2 KI) mouse line, in which CRMP2 phosphorylation by GSK3β is inhibited; however, Wallerian degeneration in CRMP2 KI mice has not yet been examined. In this study, we examined whether Wallerian degeneration of the optic nerve is suppressed in CRMP2 KI mice. Using one eye removal model, we compared Wallerian degeneration of the optic nerve based on histological and biochemical analyses. Our experimental results indicated that the genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury.

AB - Axonal degeneration occurs in patients with various neurological diseases and traumatic nerve injuries, and Wallerian degeneration is a phenomenon in the prototypical axonal degradation that is observed after injury. Collapsin response mediator protein 2 (CRMP2) is phosphorylated by glycogen synthase kinase 3β (GSK3β), and it is involved in Wallerian degeneration after optic nerve injury. We previously developed a CRMP2 knock-in (CRMP2 KI) mouse line, in which CRMP2 phosphorylation by GSK3β is inhibited; however, Wallerian degeneration in CRMP2 KI mice has not yet been examined. In this study, we examined whether Wallerian degeneration of the optic nerve is suppressed in CRMP2 KI mice. Using one eye removal model, we compared Wallerian degeneration of the optic nerve based on histological and biochemical analyses. Our experimental results indicated that the genetic inhibition of CRMP2 phosphorylation delays Wallerian degeneration after optic nerve injury.

KW - Genetic

KW - Mouse

KW - Neurodegeneration

KW - Optic nerve

KW - Phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=85065515985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065515985&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2019.05.060

DO - 10.1016/j.bbrc.2019.05.060

M3 - Article

AN - SCOPUS:85065515985

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

ER -